Non-Hodgkin lymphoma survivor thankful for clinical trial
When Ian Leybas was diagnosed with a rare type of non-Hodgkin lymphoma called peripheral T-cell lymphoma in 2019, he and his wife educated themselves on the disease and looked up treatment options.
“We were being proactive, getting multiple opinions,” says Ian, who was 45 at the time.
They lived in southeast Oklahoma and visited three different hospitals before coming to MD Anderson on Oct. 21, 2019.
“MD Anderson...
Head of Cancer Medicine: ‘MD Anderson is the place I bring my loved ones’
As a physician-scientist, I have a series of roles at MD Anderson. I’m the division head of Cancer Medicine where I oversee 16 medical oncology...
CAR T cell therapy for pediatric patients: What parents should know
CAR T cell therapy is a type of immunotherapy that modifies T cells, so they can detect and fight cancer cells. This therapy is increasingly...
Optimizing CAR T cell therapy with bridging radiation therapy
For many patients diagnosed with certain types of B-cell lymphoma, leukemia and multiple myeloma, chimeric antigen receptor (CAR) T cell therapy offers an effective treatment option. This cellular therapy is created by extracting a patient’s T cells, modifying them in a lab to identify and attack cancer cells, and returning them to the patient.
The process of creating the CAR T cells can take three to four weeks. Radiation therapy...
Need CAR T cell therapy? Here’s what to expect
CAR T cell therapy is a type of immunotherapy used to treat lymphoma, multiple myeloma and some forms of leukemia. The treatment modifies...
22 research highlights from the past year
From unlocking the secrets of the tumor microenvironment to advancing new therapies to FDA approval, MD Anderson researchers are driven by...
Helping cancer patients navigate CAR T cell therapy
Jeremiah Bergeron pays close attention to detail. As a nurse caring for hospital patients receiving CAR T cell therapy, Bergeron monitors...
CAR T cell therapy puts smoldering and multiple myeloma survivor in remission
Until she came to MD Anderson, 82-year-old Myrna Youmans had never heard the words “smoldering myeloma.” So, she didn’t know that they described...
Cancer researcher: The day I celebrated my graduation during the COVID-19 pandemic
When I enrolled at MD Anderson UTHealth Graduate School of Biomedical Sciences in 2017, I never expected to write most of my master’s thesis...
COVID-19 revaccination needed after stem cell transplants and CAR T cell therapy
If you’re a cancer patient who was fully vaccinated against COVID-19 before having a stem cell transplant or receiving a CAR T cell infusion...